Thursday, September 23rd 2021
Post Exposure Prophylaxis (PEP), the provision of antiretroviral therapy within 72 hours of a high-risk exposure is a highly effective HIV prevention tool. PEP is a critical piece or the Ending the HIV Epidemic (EHE) initiative, as it helps reduce the transmission or HIV
following exposure, and provides an opportunity for linkage to low-barrier care and risk reduction and HIV prevention tools, such as Pre-Exposure Prophylaxis (PrEP). This
webinar will discuss epidemiologic data on PEP in Philadelphia, and real-world successes and challenges, with an eye towards improving PEP delivery services in Philadelphia.
Helen C. Koenig, MD, MPH
Philadelphia Health Department